美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE	207315	001	NDA	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET;ORAL	75MG;75MG	No	No	2017/05/05 (TA)	--	HETERO LABS LTD III	None (Tentative Approval)
LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE	022344	001	NDA	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET;ORAL	300MG;300MG	Yes	No	2018/05/15	2018/05/15	AUROBINDO PHARMA LTD	Discontinued
EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE	022343	001	NDA	EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET;ORAL	600MG;300MG;300MG	Yes	No	2018/08/15	2018/08/15	AUROBINDO PHARMA LTD	Discontinued
EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE	210649	001	NDA	EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET;ORAL	400MG;300MG;300MG	No	No	2019/03/15	2019/03/15	MACLEODS PHARMS LTD	Discontinued
EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE	212786	001	ANDA	EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET;ORAL	600MG;300MG;300MG	No	No	2020/05/14	2020/05/14	LAURUS	Prescription
EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE	213038	001	ANDA	EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET;ORAL	400MG;300MG;300MG	No	No	2020/05/14	2020/05/14	LAURUS	Prescription
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE	213556	001	NDA	DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET;ORAL	50MG; 300MG; 300MG	No	No	2020/10/06 (TA)	--	SHANGHAI DESANA BIO-PHARMACEUTICALS CO LTD	None (Tentative Approval)
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE	212303	001	NDA	DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET; ORAL	50MG/300MG/300MG	No	No	2021/06/25 (TA)	--	LUPIN PHARMS	None (Tentative Approval)